ADAR1 Capital Management, LLC

InMed Pharmaceuticals Inc. · 10% Owner

ADAR1 Capital Management, LLC is listed in public filings as 10 percent owner. This ADAR1 Capital Management, LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include InMed Pharmaceuticals Inc. (INM), Rallybio Corporation (RLYB), Keros Therapeutics, Inc. (KROS), and Pieris Pharmaceuticals, Inc. (PIRS). Investors use ADAR1 Capital Management, LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
InMed Pharmaceuticals Inc.INM$312k200k sharesBuyMay 19, 2026$1.56--
InMed Pharmaceuticals Inc.INM$300k200k sharesBuyMay 19, 2026$1.50--
Rallybio CorporationRLYB$2.8k200 sharesBuyMay 19, 2026$13.80--
Rallybio CorporationRLYB$140k10k sharesBuyMay 19, 2026$13.98--
InMed Pharmaceuticals Inc.INM$110k68.6k sharesBuyMay 19, 2026$1.60--